J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on September 1, 2006

Papers In Press, published online ahead of print June 27, 2006
J. Lipid Res., doi:10.1194/jlr.M600064-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600064-JLR200v1
47/9/1975    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saad, A. F.
Right arrow Articles by Lopes-Virella, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saad, A. F.
Right arrow Articles by Lopes-Virella, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on February 7, 2006
Revised on June 15, 2006
Accepted on June 26, 2006

Autoimmune OxLDL immune-complexes activate the classical pathway of complement and induce cytokine production by mono mac 6 cells and primary human macrophages

Antonio F. Saad, Gabriel Virella, Charlyne Chassereau, Robert J. Boackle, and Maria F. Lopes-Virella

Department of Medicine, Division of Endocrinology-Metabolism-Nutrition, V.A. Strom Thurmond Research Center, Charleston, SC, Charleston, SC 29403

Corresponding Author: virellam{at}musc.edu

Oxidized LDL is immunogenic and induces autoimmune responses in humans. OxLDL antibodies are predominantly of the proinflammatory IgG1 and IgG3 isotypes. We tested the capacity of immune complexes prepared with copper-oxidized human LDL and affinity chromatography-purified human oxLDL antibodies (oxLDL-IC) to activate complement and to induce cytokine release by monomac-6 (MM6) cells and by primary human macrophages. The levels of C4d and C3a were significantly higher in human serum incubated with oxLDL-IC than after incubation with oxLDL or oxLDL antibody, indicating complement activation by the classical pathway. MM6 cells and primary human macrophages were incubated with oxLDL-IC, with or without prior conditioning with interferon-. After 18 h incubation, both MM6 cells and primary human macrophages released significantly higher levels of proinflammatory cytokines after incubation with oxLDL-IC than after incubation with oxLDL or with oxLDL antibody, both in primed and non-primed cells. OxLDL-IC were more potent activators of MM6 cells than keyhole limpet hemocyanin-IC. Blocking FcRI with monomeric IgG1 significantly depressed the response of MM6 cells to oxLDL-IC. In conclusion, human oxLDL-IC have proinflammatory properties, as reflected by their capacity to activate the classical pathway of complement and to induce pro-inflammatory cytokine release from MM6 cells and primary human macrophages.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.